Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
No immediate clinical changes to SND-AF care; leaves open validation of genetic remodeling targets.
Nof et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: